Cardio Renal

Cardio RenalCardio Renal
Cardio Renal

Cardio Renal

French digital therapeutics company developing a non-invasive potassium monitoring device for CKD patients.

Website
DR 4.42013ActiveParis, France
Rate
Advertise here

About

CardioRenal is a French company focused on improving the management of chronic kidney disease (CKD). They are developing TENOR, a digital therapeutics solution that includes a non-invasive medical device for patients to measure their blood potassium levels at home. This real-time data is then provided to physicians to help optimize treatment and prevent complications.
Frequently asked

What does Cardio Renal do?

CardioRenal is a French company focused on improving the management of chronic kidney disease (CKD). They are developing TENOR, a digital therapeutics solution that includes a non-invasive medical device for patients to measure their blood potassium levels at home. This real-time data is then provided to physicians to help optimize treatment and prevent complications.

What is Cardio Renal's revenue?

StartupHub estimates Cardio Renal's annual revenue at $3.1M (range $1.0M to $5.2M, 29% confidence), based on comparable companies in the sector.

What is Cardio Renal's valuation?

StartupHub estimates Cardio Renal's effective valuation at $54.5M (range $34.3M to $82.2M, 10% confidence), based on comparable companies in the sector.

How much funding has Cardio Renal raised?

Cardio Renal has raised a total of $14M in funding. The most recent round on record is Seed.

Where is Cardio Renal headquartered?

Cardio Renal is headquartered in Paris, France.

When was Cardio Renal founded?

Cardio Renal was founded in 2013.

What industry does Cardio Renal operate in?

Cardio Renal operates in HealthTech, MedTech, Digital Therapeutics, Chronic Kidney Disease, Remote Patient Monitoring, Medical Devices.

Comments

No comments yet. Be the first to share your take.